go back

Wyoming rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,023,293 · 10th–90th $562,341–$1,148,1540%20%40%10th90th$1,023,293Professionalmedian $562,341 · 10th–90th $562,341–$645,6540%50%90th$562,341$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $645,654.23
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $676,082.98 / $676,082.98
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$851,138.04 / $1,023,292.99 / $1,148,153.62
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $512,861.38